Breathonix develops non-invasive breath tests for disease detection. With its proprietary breath sampling device and data analysis algorithms, the company has successfully demonstrated early detection of lung cancer in a clinical study. Breathonix aims to save lives by detecting lung cancer in the earlier stages.
The technology is also promising for other diseases such as acute coronary syndromes. The long-term vision of Breathonix is to develop portable devices for breath tests, so that patients can monitor for a number of diseases through their breaths, at home.